U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H3NO3
Molecular Weight 113.0715
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-NITROFURAN

SMILES

[O-][N+](=O)C1=CC=CO1

InChI

InChIKey=FUBFWTUFPGFHOJ-UHFFFAOYSA-N
InChI=1S/C4H3NO3/c6-5(7)4-2-1-3-8-4/h1-3H

HIDE SMILES / InChI

Molecular Formula C4H3NO3
Molecular Weight 113.0715
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
2,3-Dibromo-1-(4-methyl-phen-yl)-3-(5-nitro-furan-2-yl)propan-1-one.
2010-12-11
2,3-Dibromo-1-(4-chloro-phen-yl)-3-(5-nitro-2-fur-yl)propan-1-one.
2010-11-20
2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-(4-nitro-phen-yl)propan-1-one.
2010-11-13
3-(5-Nitro-2-fur-yl)-1-phenyl-prop-2-yn-1-one.
2010-10-31
Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
2010-09
(4-Chloro-phen-yl)[1-(4-methoxy-phen-yl)-3-(5-nitro-2-fur-yl)-1H-pyrazol-4-yl]methanone.
2010-04-14
Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives.
2010-01-01
Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.
2009-12
Use of nfsB, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in Neisseria gonorrhoeae.
2009-11-23
(4-Methyl-phen-yl)[3-(5-nitro-2-fur-yl)-1-phenyl-1H-pyrazol-4-yl]methanone.
2009-11-14
5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
2009-10
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.
2009-06-16
Genetic architecture of intrinsic antibiotic susceptibility.
2009-05-20
5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
2009-02-15
Preliminary evaluation of the toxicity of some synthetic furan derivatives in two cell lines and Artemia salina.
2009-01
Genotoxicity revaluation of three commercial nitroheterocyclic drugs: nifurtimox, benznidazole, and metronidazole.
2009
Synthesis, spectroscopic, and antimicrobial studies on bivalent zinc and mercury complexes of 2-formylpyridine thiosemicarbazone.
2009
ESR, electrochemical and reactivity studies of antitrypanosomal palladium thiosemicarbazone complexes.
2008-08
Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
2008-04-15
Thiosemicarbazones active against Clostridium difficile.
2008-03-01
Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones.
2008-01
Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
2007-12-05
Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.
2007-05-01
Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.
2007
Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug.
2006-07
New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies.
2006-04
Conformational analyses and docking studies of a series of 5-nitrofuran- and 5-nitrothiophen-semicarbazone derivatives in three possible binding sites of trypanothione and glutathione reductases.
2006-03
In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
2004-09-15
Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
2004-05
Analysis of 5-nitrofuran derivatives in biological objects.
2003-01
Investigation of 5-nitrofuran derivatives: synthesis, antibacterial activity, and quantitative structure-activity relationships.
2001-10-25
Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin.
2001-04-05
Synthesis and antibacterial activity of 5-nitrofuryl and 3-methoxy-2-nitrophenyl derivatives of 6 beta-aminopenicillanic, 7 beta-aminocephalosporanic and 7 beta-aminodesacetoxy-cephalosporanic acids.
2001
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:05:23 GMT 2025
Edited
by admin
on Mon Mar 31 19:05:23 GMT 2025
Record UNII
17EZI4D981
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-NITROFURAN
Systematic Name English
NSC-59983
Preferred Name English
5-NITROFURAN
Systematic Name English
FURAN, 2-NITRO-
Systematic Name English
NITROFURAN
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID80870682
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
FDA UNII
17EZI4D981
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
CHEBI
34890
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
NSC
59983
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
SMS_ID
100000176578
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
CAS
609-39-2
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY
PUBCHEM
11865
Created by admin on Mon Mar 31 19:05:23 GMT 2025 , Edited by admin on Mon Mar 31 19:05:23 GMT 2025
PRIMARY